Ribosomal protein L32 enhances hepatocellular carcinoma progression

PURPOSE: The underlying mechanisms of hepatocellular carcinoma (HCC) have not been fully investigated, and effective biomarkers for HCC are still needed to be explored. Therefore, our study sought to thoroughly examine the clinical significance and biological functions of the ribosomal protein L32 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Guoxin, Lu, Zhimin, Jiang, Jialu, Yang, Xinmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225200/
https://www.ncbi.nlm.nih.gov/pubmed/37017565
http://dx.doi.org/10.1002/cam4.5811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225200/
https://www.ncbi.nlm.nih.gov/pubmed/37017565
http://dx.doi.org/10.1002/cam4.5811

Ejemplares similares